`To:
`Cc:
`Subject:
`Date:
`
`Munoz, Ruben
`White, Brandon (WDC); Beel, Bryan D. (POR)
`JANS-ZYTIGA; ZytigaIPRTeam@sidley.com
`Deposition of Dr. Serels in IPR2016-00286
`Friday, August 19, 2016 9:46:56 AM
`
`Brandon:
`
`Counsel for Amerigen has informed us that you intend to attend the deposition of Dr. Serels in
`IPR2016-00286 (the “Amerigen IPR”) on behalf of Mylan. As you know, Mylan is not a party to the
`Amerigen IPR. In fact, as you represented to the Board in IPR2016-01332, “Dr. Serels . . . is not
`Mylan’s expert and . . . Amerigen has not agreed that Mylan can retain Dr. Serels.” Thus, Janssen
`objects to your presence at Dr. Serels’ deposition and will not permit your attendance.
`
`Best regards,
`
`Ruben
`
`
`
`Ruben H. Muñoz
`AKIN GUMP STRAUSS HAUER & FELD LLP
`Two Commerce Square | 2001 Market Street | Suite 4100 | Philadelphia, PA 19103-7013 | USA | Direct: +1
`215.965.1263 | Internal: 21263
`Fax: +1 215.965.1210 | Mobile: +1 215.807.9595 | rmunoz@akingump.com | akingump.com | Bio
`
`
`The information contained in this e-mail message is intended only for the personal and
`confidential use of the recipient(s) named above. If you have received this communication in
`error, please notify us immediately by e-mail, and delete the original message.
`
`MYLAN PHARMS. INC. EXHIBIT 1148 PAGE 1
`
`